Literature DB >> 16988058

Ischemic preconditioning provides both acute and delayed protection against renal ischemia and reperfusion injury in mice.

Jin Deok Joo1, Mihwa Kim, Vivette D D'Agati, H Thomas Lee.   

Abstract

Acute as well as delayed ischemic preconditioning (IPC) provides protection against cardiac and neuronal ischemia reperfusion (IR) injury. This study determined whether delayed preconditioning occurs in the kidney and further elucidated the mechanisms of renal IPC in mice. Mice were subjected to IPC (four cycles of 5 min of ischemia and reperfusion) and then to 30 min of renal ischemia either 15 min (acute IPC) or 24 h (delayed IPC) later. Both acute and delayed renal IPC provided powerful protection against renal IR injury. Inhibition of Akt but not extracellular signal-regulated kinase phosphorylation prevented the protection that was afforded by acute IPC. Neither extracellular signal-regulated kinase nor Akt inhibition prevented protection that was afforded by delayed renal IPC. Pretreatment with an antioxidant, N-(2-mercaptopropionyl)-glycine, to scavenge free radicals prevented the protection that was provided by acute but not delayed renal IPC. Inhibition of protein kinase C or pertussis toxin-sensitive G-proteins attenuated protection from both acute and delayed renal IPC. Delayed renal IPC increased inducible nitric oxide synthase (iNOS) as well as heat-shock protein 27 synthesis, and the renal protective effects of delayed preconditioning were attenuated by a selective inhibitor of iNOS (l-N(6)[1-iminoethyl]lysine). Moreover, delayed IPC was not observed in iNOS knockout mice. Both acute and delayed IPC were independent of A(1) adenosine receptors (AR) as a selective A(1)AR antagonist failed to block preconditioning and acute and delayed preconditioning occurred in mice that lacked A(1)AR. Therefore, this study demonstrated that acute or delayed IPC provides renal protection against IR injury in mice but involves distinct signaling pathways.

Entities:  

Mesh:

Year:  2006        PMID: 16988058     DOI: 10.1681/ASN.2006050424

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  50 in total

Review 1.  Molecular mechanisms of ischemic preconditioning in the kidney.

Authors:  Pinelopi P Kapitsinou; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-26

2.  Activation of hypoxia-inducible factor-1 ameliorates postischemic renal injury via inducible nitric oxide synthase.

Authors:  Xiao-Li Zhang; Zhen-Wen Yan; Wei-Wen Sheng; Jing Xiao; Zhen-Xing Zhang; Zhi-Bin Ye
Journal:  Mol Cell Biochem       Date:  2011-07-14       Impact factor: 3.396

3.  Inducible nitric oxide synthase promoter polymorphism affords protection against cognitive dysfunction after carotid endarterectomy.

Authors:  Gene T Yocum; John G Gaudet; Susie S Lee; Yaakov Stern; Lauren A Teverbaugh; Robert R Sciacca; Charles W Emala; Donald O Quest; Paul C McCormick; James F McKinsey; Nicholas J Morrissey; Robert A Solomon; E Sander Connolly; Eric J Heyer
Journal:  Stroke       Date:  2009-03-12       Impact factor: 7.914

4.  Effects of ischemic preconditioning on the systemic and renal hemodynamic changes in renal ischemia reperfusion injury.

Authors:  Yu-Zheng Ge; Ran Wu; Hui Xin; Hao Liu; Tian-Ze Lu; You-Cai Zhao; Jiang-Wei Shen; Zhi-Kai Hu; Peng Yu; Liu-Hua Zhou; Lu-Wei Xu; Zheng Xu; Jian-Ping Wu; Wen-Cheng Li; Jia-Geng Zhu; Rui-Peng Jia
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

5.  Atherosclerotic renal artery stenosis is associated with elevated cell cycle arrest markers related to reduced renal blood flow and postcontrast hypoxia.

Authors:  Ahmed Saad; Wei Wang; Sandra M S Herrmann; James F Glockner; Michael A Mckusick; Sanjay Misra; Haraldur Bjarnason; Lilach O Lerman; Stephen C Textor
Journal:  Nephrol Dial Transplant       Date:  2016-07-29       Impact factor: 5.992

6.  Protective Effect of Tempol on Acute Kidney Injury Through PI3K/Akt/Nrf2 Signaling Pathway.

Authors:  Gensheng Zhang; Qiaoling Wang; Qin Zhou; Renjun Wang; Minze Xu; Huiping Wang; Lei Wang; Christopher S Wilcox; Ruisheng Liu; En Yin Lai
Journal:  Kidney Blood Press Res       Date:  2016-02-22       Impact factor: 2.687

7.  Pharmacological induction of hypoxia-inducible transcription factor ARNT attenuates chronic kidney failure.

Authors:  Björn Tampe; Désirée Tampe; Gunsmaa Nyamsuren; Friederike Klöpper; Gregor Rapp; Anne Kauffels; Thomas Lorf; Elisabeth M Zeisberg; Gerhard A Müller; Raghu Kalluri; Samy Hakroush; Michael Zeisberg
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

8.  Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis.

Authors:  Katalin Módis; Domokos Gero; Nóra Nagy; Petra Szoleczky; Zoltán Dóri Tóth; Csaba Szabó
Journal:  Br J Pharmacol       Date:  2009-11       Impact factor: 8.739

9.  Exogenous Gene Transmission of Isocitrate Dehydrogenase 2 Mimics Ischemic Preconditioning Protection.

Authors:  Alexander L Kolb; Peter R Corridon; Shijun Zhang; Weimin Xu; Frank A Witzmann; Jason A Collett; George J Rhodes; Seth Winfree; Devin Bready; Zechariah J Pfeffenberger; Jeremy M Pomerantz; Takashi Hato; Glenn T Nagami; Bruce A Molitoris; David P Basile; Simon J Atkinson; Robert L Bacallao
Journal:  J Am Soc Nephrol       Date:  2018-01-25       Impact factor: 10.121

Review 10.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.